Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · IEX Real-Time Price · USD
2.675
+0.155 (6.15%)
Jul 22, 2024, 10:01 AM EDT - Market open
Cellectar Biosciences Employees
Cellectar Biosciences had 20 employees as of December 31, 2023. The number of employees increased by 5 or 33.33% compared to the previous year.
Employees
20
Change (1Y)
5
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,549,193
Market Cap
99.66M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
111, Inc. | 1,520 |
LakeShore Biopharma | 773 |
Alpha Teknova | 211 |
Asensus Surgical | 209 |
Assembly Biosciences | 65 |
InflaRx | 62 |
BeyondSpring | 36 |
Eton Pharmaceuticals | 30 |
CLRB News
- 3 hours ago - Cellectar Biosciences Announces Exercise of Tranche B Warrants and Purchase of New Warrants for Approximately $19.4 million with the Potential to Raise Up to an Additional $73.3 Million - GlobeNewsWire
- 25 days ago - Cellectar Biosciences to Host Key Opinion Leader Event to Review the Full Results from Its CLOVER WaM Pivotal Trial and Waldenstrom's Macroglobulinemia Market Landscape - GlobeNewsWire
- 7 weeks ago - Cellectar Biosciences and City of Hope Cancer Center Enter Collaboration to Evaluate Iopofosine I 131 in Mycosis Fungoides - GlobeNewsWire
- 2 months ago - Cellectar Biosciences Reports Financial Results for Q1 2024 and Provides a Corporate Update - GlobeNewsWire
- 2 months ago - Cellectar Biosciences to Present at the Guggenheim Healthcare Talks Radiopharmaceuticals Day - GlobeNewsWire
- 2 months ago - Cellectar Biosciences to Announce First Quarter Financial Results and Host a Conference Call on Tuesday, May 14, 2024 - GlobeNewsWire
- 4 months ago - Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update - GlobeNewsWire
- 4 months ago - Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024 - GlobeNewsWire